Categories
Archives
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- March 2010
- February 2010
- January 2010
< Back to Press Releases
Monthly Archives: November 2012
Digoxin increases deaths in patients with atrial fibrillation
Digoxin, a drug that has been used worldwide for centuries to treat heart disease, is associated with a significant increase in deaths in patients with atrial fibrillation (AF), according to results from a study published online in the European Heart … Continue reading
Published Wednesday, November 28th, 2012 at 12:05 am
Posted in Cardiology
Relatives of people who die suddenly from heart problems have greatly increased risk of cardiovascular disease
Relatives of young people who have died suddenly from a heart-related problem are at greatly increased risk of developing cardiovascular disease according to a study published online in the European Heart Journal [1]. The authors of the study say these … Continue reading
Published Wednesday, November 14th, 2012 at 12:05 am
Posted in Cardiology, Genetics
First trial in humans of “minicells”: a completely new way of delivering anti-cancer drugs
A completely new way of delivering anti-cancer drugs to tumours, using “minicells” derived from bacteria, has been tested for the first time in humans and found to be safe, well-tolerated and even induced stable disease in patients with advanced, incurable … Continue reading
Published Friday, November 9th, 2012 at 12:01 am
Posted in Cancer
Molecular ‘portraits’ of tumours match patients with trials in everyday clinical practice
Researchers in France are taking advantage of the progress in genetic and molecular profiling to analyse the make-up of individual cancer patients’ tumours and, using this information, assign them to particular treatments and phase I clinical trials – an approach … Continue reading
Published Friday, November 9th, 2012 at 12:01 am
Posted in Cancer
Mesothelioma drug slows disease progression in patients with an inactive NF2 gene
Preliminary findings from the first trial of a new drug for patients with mesothelioma show that it has some success in preventing the spread of the deadly disease in patients lacking an active tumour suppressor gene called NF2. The study … Continue reading
Published Friday, November 9th, 2012 at 12:01 am
Posted in Cancer
New targeted therapy for advanced prostate cancer shows anti-tumour activity in phase I clinical trials
Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory prostate cancer usually die from the … Continue reading
Published Thursday, November 8th, 2012 at 12:01 am
Posted in Cancer
Researchers develop non-invasive technique for predicting patients’ response to chemotherapy
Researchers have developed a non-invasive way of predicting how much of a cancer-killing drug is absorbed by a tumour. The preliminary study, which was reported at the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, … Continue reading
Published Thursday, November 8th, 2012 at 12:01 am
Posted in Cancer
Patients with aberrations in two genes respond better to drugs blocking a well-known cancer pathway
Cancer patients with mutations or variations in two genes – PIK3CA and PTEN – who have failed to respond to several, standard treatments, respond significantly better to anti-cancer drugs that inhibit these genes’ pathways of action, according to research presented … Continue reading
Published Thursday, November 8th, 2012 at 12:01 am
Posted in Cancer
New monoclonal antibody inhibits tumour growth in advanced solid tumours in a phase I clinical trial
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers reported at the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer … Continue reading
Published Wednesday, November 7th, 2012 at 12:01 am
Posted in Cancer
Scientists test 5000 combinations of 100 existing cancer drugs to find more effective treatments
Scientists in the United States have tested all possible pairings of the 100 cancer drugs approved for use in patients in order to discover whether there are any combinations not tried previously that are effective in certain cancers. Dr Susan … Continue reading
Published Wednesday, November 7th, 2012 at 12:01 am
Posted in Cancer